Enclomiphene API Manufacturers

Looking for Enclomiphene API 15690-57-0?

Description:

Here you will find a list of producers, manufacturers and distributors of Enclomiphene. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Enclomiphene 

Synonyms:

Clomiphene trans-form  

Cas Number:

15690-57-0 

DrugBank number:

DB06735 

Unique Ingredient Identifier:

R6D2UI4FLS

Enclomiphene is a type of Selective estrogen receptor modulators (SERMs)

Selective estrogen receptor modulators (SERMs) belong to a category of pharmaceutical active ingredients (APIs) that interact with estrogen receptors in a selective manner. SERMs are designed to exert distinct effects on specific tissues by binding to estrogen receptors, which are found in various parts of the body. These compounds exhibit both estrogenic and anti-estrogenic properties, depending on the target tissue.

One of the key applications of SERMs is in the treatment of hormone-related conditions such as breast cancer, osteoporosis, and menopausal symptoms. They function by selectively binding to estrogen receptors in breast tissue, thereby inhibiting the growth-promoting effects of estrogen and reducing the risk of breast cancer. In the case of osteoporosis, SERMs stimulate bone formation and help maintain bone density.

Moreover, SERMs have shown efficacy in managing menopausal symptoms such as hot flashes, vaginal dryness, and mood swings. By binding to estrogen receptors in the brain, they alleviate these symptoms without stimulating the growth of estrogen-dependent tissues like the uterus.

Some commonly known SERMs include tamoxifen, raloxifene, and ospemifene. These compounds have undergone rigorous clinical trials and have been approved by regulatory authorities for specific indications.

In summary, SERMs are a class of pharmaceutical APIs that selectively interact with estrogen receptors, exerting estrogenic or anti-estrogenic effects depending on the target tissue. They have proven to be valuable therapeutic agents in the management of breast cancer, osteoporosis, and menopausal symptoms.

• Xi'an ZB Biotech Co., Ltd from China, product country of origin China
• PCAS from France, product country of origin Unknown

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.